Trade Winds Shift for Pharma: Understanding the Section 232 Tariff Proclamation on Pharmaceuticals
This Advisory explains how recent U.S. trade policies, particularly new tariffs and related measures targeting pharmaceuticals and ingredients, are reshaping global pharma supply chains, pricing, and contracting strategies while outlining key legal and operational considerations for companies navigating this shifting landscape.
News & Perspectives3mo ago 
